Targeting the Gut-Brain Axis with Fecal Microbiota Transplantation: Considerations on a Potential Novel Treatment for Parkinson's Disease

Overview

Journal Mov Disord Clin Pract

Publisher Wiley

Specialty Neurology

Date 2023 Aug 28

PMID 37637989

Authors

Maria Fiorella Contarino

Jacobus J van Hilten

Ed J Kuijper

Affiliations

Soon will be listed here.

Citing Articles

Gut microbiota and Parkinson's disease: potential links and the role of fecal microbiota transplantation.

Feng M, Zou Z, Shou P, Peng W, Liu M, Li X Front Aging Neurosci. 2024; 16:1479343.

PMID: 39679259 PMC: 11638248. DOI: 10.3389/fnagi.2024.1479343.

The gut-brain-metabolic axis: exploring the role of microbiota in insulin resistance and cognitive function.

Abildinova G, Benberin V, Vochshenkova T, Afshar A, Mussin N, Kaliyev A Front Microbiol. 2024; 15:1463958.

PMID: 39659426 PMC: 11628546. DOI: 10.3389/fmicb.2024.1463958.

Exploring potential polysaccharide utilization loci involved in the degradation of typical marine seaweed polysaccharides by .

Yu B, Lu Z, Zhong S, Cheong K Front Microbiol. 2024; 15:1332105.

PMID: 38800758 PMC: 11119289. DOI: 10.3389/fmicb.2024.1332105.

Safety and feasibility of faecal microbiota transplantation for patients with Parkinson's disease: a protocol for a self-controlled interventional donor-FMT pilot study.

Vendrik K, Chernova V, Kuijper E, Terveer E, van Hilten J, Contarino M BMJ Open. 2023; 13(10):e071766.

PMID: 37798034 PMC: 10565159. DOI: 10.1136/bmjopen-2023-071766.

Unanswered Questions in Clinical Practice.

Lynch T, Gershanik O Mov Disord Clin Pract. 2023; 10(Suppl 2):S5-S8.

PMID: 37637984 PMC: 10448123. DOI: 10.1002/mdc3.13837.

References

Horsager J, Andersen K, Knudsen K, Skjaerbaek C, Fedorova T, Okkels N . Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study. Brain. 2020; 143(10):3077-3088. DOI: 10.1093/brain/awaa238. View

Ulusoy A, Rusconi R, Perez-Revuelta B, Musgrove R, Helwig M, Winzen-Reichert B . Caudo-rostral brain spreading of α-synuclein through vagal connections. EMBO Mol Med. 2013; 5(7):1119-27. PMC: 3721477. DOI: 10.1002/emmm.201302475. View

Sun M, Zhu Y, Zhou Z, Jia X, Xu Y, Yang Q . Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway. Brain Behav Immun. 2018; 70:48-60. DOI: 10.1016/j.bbi.2018.02.005. View

Leclair-Visonneau L, Neunlist M, Derkinderen P, Lebouvier T . The gut in Parkinson's disease: Bottom-up, top-down, or neither?. Neurogastroenterol Motil. 2019; 32(1):e13777. DOI: 10.1111/nmo.13777. View

Jackson A, Forsyth C, Shaikh M, Voigt R, Engen P, Ramirez V . Diet in Parkinson's Disease: Critical Role for the Microbiome. Front Neurol. 2020; 10:1245. PMC: 6915094. DOI: 10.3389/fneur.2019.01245. View

Holmqvist S, Chutna O, Bousset L, Aldrin-Kirk P, Li W, Bjorklund T . Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol. 2014; 128(6):805-20. DOI: 10.1007/s00401-014-1343-6. View

Vendrik K, Chernova V, Kuijper E, Terveer E, van Hilten J, Contarino M . Safety and feasibility of faecal microbiota transplantation for patients with Parkinson's disease: a protocol for a self-controlled interventional donor-FMT pilot study. BMJ Open. 2023; 13(10):e071766. PMC: 10565159. DOI: 10.1136/bmjopen-2023-071766. View

Romano S, Savva G, Bedarf J, Charles I, Hildebrand F, Narbad A . Meta-analysis of the Parkinson's disease gut microbiome suggests alterations linked to intestinal inflammation. NPJ Parkinsons Dis. 2021; 7(1):27. PMC: 7946946. DOI: 10.1038/s41531-021-00156-z. View

Postuma R, Aarsland D, Barone P, Burn D, Hawkes C, Oertel W . Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease. Mov Disord. 2012; 27(5):617-26. DOI: 10.1002/mds.24996. View

10.

Svensson E, Horvath-Puho E, Thomsen R, Djurhuus J, Pedersen L, Borghammer P . Vagotomy and subsequent risk of Parkinson's disease. Ann Neurol. 2015; 78(4):522-9. DOI: 10.1002/ana.24448. View

11.

Cilia R, Piatti M, Cereda E, Bolliri C, Caronni S, Ferri V . Does Gut Microbiota Influence the Course of Parkinson's Disease? A 3-Year Prospective Exploratory Study in de novo Patients. J Parkinsons Dis. 2020; 11(1):159-170. DOI: 10.3233/JPD-202297. View

12.

Wang S, Xu M, Wang W, Cao X, Piao M, Khan S . Systematic Review: Adverse Events of Fecal Microbiota Transplantation. PLoS One. 2016; 11(8):e0161174. PMC: 4986962. DOI: 10.1371/journal.pone.0161174. View

13.

Seekatz A, Aas J, Gessert C, Rubin T, Saman D, Bakken J . Recovery of the gut microbiome following fecal microbiota transplantation. mBio. 2014; 5(3):e00893-14. PMC: 4068257. DOI: 10.1128/mBio.00893-14. View

14.

Terveer E, Vendrik K, Ooijevaar R, van Lingen E, Boeije-Koppenol E, van Nood E . Faecal microbiota transplantation for infection: Four years' experience of the Netherlands Donor Feces Bank. United European Gastroenterol J. 2020; 8(10):1236-1247. PMC: 7724536. DOI: 10.1177/2050640620957765. View

15.

Huang H, Xu H, Luo Q, He J, Li M, Chen H . Fecal microbiota transplantation to treat Parkinson's disease with constipation: A case report. Medicine (Baltimore). 2019; 98(26):e16163. PMC: 6616439. DOI: 10.1097/MD.0000000000016163. View

16.

Perler B, Chen B, Phelps E, Allegretti J, Fischer M, Ganapini V . Long-Term Efficacy and Safety of Fecal Microbiota Transplantation for Treatment of Recurrent Clostridioides difficile Infection. J Clin Gastroenterol. 2020; 54(8):701-706. DOI: 10.1097/MCG.0000000000001281. View

17.

Vendrik K, Ooijevaar R, de Jong P, Laman J, van Oosten B, van Hilten J . Fecal Microbiota Transplantation in Neurological Disorders. Front Cell Infect Microbiol. 2020; 10:98. PMC: 7105733. DOI: 10.3389/fcimb.2020.00098. View

18.

Brooks D . Examining Braak's hypothesis by imaging Parkinson's disease. Mov Disord. 2010; 25 Suppl 1:S83-8. DOI: 10.1002/mds.22720. View

19.

Yang X, Zhou R, Di W, He Q, Huo Q . Clinical therapeutic effects of probiotics in patients with constipation associated with Parkinson disease: A protocol for systematic review and meta-analysis. Medicine (Baltimore). 2021; 100(44):e27705. PMC: 8568397. DOI: 10.1097/MD.0000000000027705. View

20.

Maini Rekdal V, Bess E, Bisanz J, Turnbaugh P, Balskus E . Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism. Science. 2019; 364(6445). PMC: 7745125. DOI: 10.1126/science.aau6323. View